Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Date Title and Summary View
Dec 22, 2011
- Second PTC Discovery Program Funded by Seeding Drug Discovery Award -
Additional Formats
Nov 29, 2011
Collaboration offers new hope for a potential treatment for the leading genetic cause of death in infants and toddlers
Additional Formats
Nov 07, 2011
South Plainfield, NJ– November 7, 2011 - PTC Therapeutics, Inc. announced today that it will receive funding through Grand Challenges Explorations, an initiative created by the Bill & Melinda Gates Foundation that enables researchers worldwide to test unorthodox ideas that address persistent health
Additional Formats
Sep 02, 2011
- PTC Regains Worldwide Rights to Ataluren in Duchenne and Becker Muscular Dystrophies -
Additional Formats
Jul 01, 2011
SOUTH PLAINFIELD, NJ – July 1, 2011 – PTC Therapeutics, Inc. (PTC) today announced the publication of data from a Phase 2 study of ataluren, an investigational new drug, in adults with nonsense mutation cystic fibrosis (nmCF) in the European Respiratory Journal.
Additional Formats
Jun 29, 2011
ALDERLEY PARK, UK and SOUTH PLAINFIELD, N.J., June 29, 2011 – AstraZeneca and PTC Therapeutics, Inc. (PTC) today announced that they have entered into an exclusive research collaboration and license agreement for the application of PTC's proprietary GEMS™ technology (Gene Expression Modulation by
Additional Formats
Mar 30, 2011
- Jay Barth, M.D. Promoted to Vice President of Clinical Development -
Additional Formats
Mar 02, 2011
- PTC Receives $2.2 Million Payment -
Additional Formats
Feb 01, 2011
- PPMD awards $250,000 grant towards research program-
Additional Formats
Jan 19, 2011
SOUTH PLAINFIELD, NJ – January 19, 2011 – Stuart W. Peltz, Ph.D., President and CEO of PTC Therapeutics, Inc. (PTC), has been elected a Fellow of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.
Additional Formats